‘EXPANDING BUSINESS IN AFRICA, ASIA, CIS, LATIN AMERICA’

“There is an exciting environment when people are motivated to work more and deliver more. In 2022 as well, we are looking at evaluating the areas that will attract growth for a good five to ten years period. In the oncology or rare diseases sector, there is certainly a competitive edge we can bear and can rely on. We have a range of high-quality formulations in Oncology and Critical Care while adhering to global quality standards. Cost-effectiveness has been our strength and we are looking at expanding our business in Africa, Latin America, Asia and CIS region. We will continue to deliver non-infringing and innovative products within the regulatory framework.”

- M NAGESH KUMAR,

Managing Director, Celon Labs, Hyderabad